IRCT20200105046010N77招募中Unknown
Bioequivalence study of Telmisartan 80 mg tablet manufactured by Cobel daru versus originator brand in healthy volunteers in the fasted condition
Cobel Darou Pharmaceutical Company0 个研究点目标入组 24 人开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 55 years（—）
- 性别
- All
入选标准
- •General Health (Liver, Heart, and Kidney)
- •Body Mass Index (18-28)
- •Informed consent
- •Age (18-55 years old)
排除标准
- 未提供
研究者
相似试验
已完成
1 期
Bioequivalence of Telmisartan Film-coated Tablet Compared With Two Tablets of the Conventional Telmisartan Tablet in Healthy Male VolunteersHealthyNCT02261129Boehringer Ingelheim64
已完成
1 期
Bioequivalence of Telmisartan / HCTZ Fixed Dose Combination Compared to Its Monocomponents in Healthy Male VolunteersHealthyNCT02262624Boehringer Ingelheim36
已完成
1 期
Bioequivalence of Telmisartan/ HCTZ Fixed Dose Combination Compared With Its Monocomponents in Healthy Male Volunteers IIHealthyNCT02262858Boehringer Ingelheim68
招募中
Unknown
Investigating bioequivalence of valsartan tabletIn the present study, the products will be administered to healthy volunteers..IRCT20220211053992N15Tabriz University of Medical Sciences24
已完成
1 期
Bioequivalence of Telmisartan/g Ramipril Fixed Dose Combination Compared With the Monocomponents Telmisartan and Ramipril (Two Different Formulations) Given Concomitantly to Healthy Male and Female VolunteersHealthyNCT02214992Boehringer Ingelheim84